Cantourage Group SE (FRA:HIGH)
3.210
-0.040 (-1.23%)
At close: Jan 9, 2026
Cantourage Group SE Company Description
Cantourage Group SE operates as a medical cannabis company in Europe and internationally.
The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products.
It exports its products. The company distributes its products through pharmacies, wholesalers, and partners.
Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.
Cantourage Group SE
| Country | Germany |
| Founded | 2019 |
| Industry | Pharmaceutical Preparations |
| Employees | 7 |
| CEO | Philip Schetter |
Contact Details
Address: Feurigstr. 54 Berlin, 10827 Germany | |
| Phone | 49 30 4701 350 51 |
| Website | cantourage.com |
Stock Details
| Ticker Symbol | HIGH |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Philip Schetter | Chief Executive Officer |
| Manuel Taverne | Head of Investor Relations |